Company intelligence / Profile preview

Infinant Health

Davis, California, USAinfinanthealth.com ↗
Ownership
Private
Employees
~75
Development stage
Commercial
01

Overview

The company’s lead product Evivo®—a daily probiotic powder containing activated B. infantis EVC001—has demonstrated efficacy in restoring healthy gut bacteria in infants fed breast milk. Clinical studies show it reduces pathogenic bacteria by up to 80% and significantly lowers intestinal inflammation associated with a range of short-term and long-term health risks such as NEC and allergies. The company continues to expand its clinical research into new pediatric indications including atopic dermatitis prevention.

Therapeutic areas
GastroenterologyDermatology
Modalities
Probiotics/microbial therapeutics (notably B. infantis EVC001)Medical foods/dietary supplementsDigital health medical devices (in development)
Industry
Biotech
02

Drug pipeline

1 asset

Evivo

Unknown
03

Partnerships

CargillManna Tree PartnersBill & Melinda Gates FoundationHorizons VenturesJohnson & Johnson Development CorporationConnected World Without Disease Accelerator (CWWDA)UC Davis/Foods For Health Institute

Beyond the preview

Go deeper on Infinant Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infinant Health.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call